ENTA
ENANTA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$11.41
+2.79%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 5.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.29x
- Price / sales
- 5.09x
- Price / cash flow
- -9.41x
Enterprise value
- Enterprise value
- $198.5M
- EV / sales
- 3.04x
- EV / EBITDA
- -4.38x
- EV / EBIT
- -3.38x
- Market cap
- $332.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026